TOPBP1作为一种潜在的预测生物标志物,用于在PDAC中增强olaparib和AZD6738的组合疗效
Xiao-Mei Tang1,2,3, Min-Min Shi1,3, Jia-Cheng Wang4,5
1Department of General Surgery, Pancreatic Disease Center, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China.
Cell & bioscience
|February 7, 2025
概括
高TOBP1表达与胰腺癌生存率差相关. 向TOPB1提高了olaparib的疗效,并建议TOPB1作为组合治疗的生物标志物.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 胰腺管腺癌 (PDAC) 是一种具有频繁的DNA损伤反应 (DDR) 途径改变的侵袭性癌症.
- 基因突酶II结合蛋白1 (TOPBP1) 涉及DDR和癌症瘤发生.
研究的目的:
- 研究TOPBP1在PDAC病变发生中的作用.
- 评估TOPBP1作为PDAC治疗反应的预测生物标志物.
主要方法:
- 在PDAC细胞系,原始细胞和小鼠模型中检查了TOPB1表达.
- 评估了TOPBP1淘汰对olaparib敏感性的影响.
- 研究了用olaparib和AZD6738的组合疗法,重点关注DDR通路 (ATR,ATM) 和亡.
主要成果:
- 较高的TOBP1表达与较高的PDAC等级和降低的存活率相关.
- TOPBP1 knockdown使PDAC细胞对olaparib敏感,提高了治疗疗效.
- 结合olaparib和AZD6738诱导了亡和降低活力,特别是在高TOBP1表达细胞中.
结论:
- TOPBP1在PDAC进展中发挥着重要作用.
- 在PDAC患者中,TOPBP1可以作为优化olaparib和AZD6738联合治疗的预测生物标志物.
相关概念视频
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...